Online citations, reference lists, and bibliographies.
← Back to Search

Principles Of Encapsulating Hydrophobic Drugs In PLA/PLGA Microparticles.

C. Wischke, S. Schwendeman
Published 2008 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Injectable biodegradable and biocompatible copolymers of lactic and glycolic acid (PLGA) are an important advanced delivery system for week-to-month controlled release of hydrophobic drugs (e.g., from biopharmaceutical classification system class IV), which often display poor oral bioavailability. The basic principles and considerations to develop such microparticle formulations is reviewed here based on a comprehensive study of papers and patents from the beginnings of hydrophobic drug encapsulation in polylactic acid and PLGA up through the very recent literature. Challenges with the diversity of drug properties, microencapsulation methods, and organic solvents are evaluated in light of the precedence of commercialized formulations and with a focus on decreasing the time to lab-scale encapsulation of water-insoluble drug candidates in the early stage of drug development. The influence of key formulation variables on final microparticle characteristics, and how best to avoid undesired microparticle properties, is analyzed mechanistically. Finally, concepts are developed to manage the common issues of maintaining sink conditions for in vitro drug release assays of hydrophobic compounds. Overall, against the backdrop of an increasing number of new, poorly orally available drug entities entering development, microparticle delivery systems may be a viable strategy to rescue an otherwise undeliverable substance.
This paper references
10.1211/0022357991772943
Effect of Solvent Composition During Preparation on the Characteristics of Enoxacin Microparticles
Q. Yang (1999)
10.1016/J.ADDR.2004.09.003
Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
Wenlei Jiang (2005)
10.1002/JPS.2600630136
CMC of polysorbates.
L. Wan (1974)
10.2165/00128415-199405320-00063
Triamcinolone acetonide
A. Kaminsky (1958)
10.1002/(SICI)1097-4636(19970315)34:4<531::AID-JBM13>3.0.CO;2-F
Effects of metal salts on poly(DL-lactide-co-glycolide) polymer hydrolysis.
Y. Zhang (1997)
Langwirkende bioabbaubare Mikropartikel und ein Verfahren zur Herstellung
N. ill (1995)
However, if the solvent is too soluble in water, nd/or a large volume of water is used, very fast solidification of he polymer may occur, forming a dense polymer shell around
ao (2008)
Über den Polyvinylalkohol
W. O. errmann (1927)
Microencapsulated 3-Piperidinylsubstituted 1,2-benzisooxazoles and 1,2-benzisothiazoles
J Mesens
10.1248/CPB.52.976
Influence of manufacturing parameters on development of contraceptive steroid loaded injectable microspheres.
M. Dhanaraju (2004)
10.1002/JPS.2600550625
Solubility or Some Steroids in Water
P. Kabasakalian (1966)
Biodegradable low molecular weight tri
R. December. athi (2001)
Hazardous Material Handbook
R P Pohanish (1996)
Process for encapsulatingwater and compounds in aqueous phase by evaporation
M. N. rancken (1970)
10.1016/J.ADDR.2007.05.005
Computational approaches to determine drug solubility.
B. Faller (2007)
In vivo characterization of sustained-release formulations of human growth hormone.
H. Lee (1997)
10.1016/J.JCONREL.2007.01.016
Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
G. Mittal (2007)
10.1016/S0927-7765(99)00162-9
Synthesis, characterization and protein adsorption behaviors of PLGA/PEG di-block co-polymer blend films.
Jeong (2000)
Lipoid pneumonia following attempted suicide
B. E. Strauer (2001)
10.1023/A:1016482809810
A Novel in Vitro Delivery System for Assessing the Biological Integrity of Protein upon Release from PLGA Microspheres
A. Aubert-Pouëssel (2004)
Food effects on drug
B. February. yers-Davit (2008)
10.1016/J.CBPA.2006.06.015
Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery.
M. V. S. Varma (2006)
10.1016/S0168-3659(98)00173-4
Adsorption of serum albumin to thin films of poly(lactide-co-glycolide).
S. Butler (1999)
10.1021/JS970047R
Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations.
C. Thomasin (1998)
10.1080/02652040110105319
Ethyl acetate as a dispersing solvent in the production of poly(DL-lactide-co-glycolide) microspheres: effect of process parameters and polymer type
K. Soppimath (2002)
10.1016/0168-3659(91)90071-K
Preparation of poly(l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate
S. Izumikawa (1991)
Composition for the sustained release of human growth hormone.
O. Johnson (1996)
10.1016/S0168-3659(99)00118-2
Gamma irradiation for terminal sterilization of 17beta-estradiol loaded poly-(D,L-lactide-co-glycolide) microparticles.
D. Mohr (1999)
10.1016/S0378-5173(98)00133-1
The effects of drug physico-chemical properties on release from copoly (lactic/glycolic acid) matrix
M. Miyajima (1998)
10.1002/CITE.200406163
Emulgieren: Mehr als nur Zerkleinern
H. Schuchmann (2004)
It is mportant to point out that in the former case, the carrier solent must first dissolve in the continuous phase before evaporation akes place
Vrancken (2005)
Octreotidepamoat und dessen Verwendung zur Herstellung von pharmazeutischen Formulierungen
D. odmer (1996)
10.1016/s0169-409x(96)00423-1
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
C. Lipinski (2001)
10.1016/S0378-5173(00)00568-8
Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems.
H. Kranz (2001)
Sustained release microcapsule
M. amamoto (1994)
10.1080/026520400288319
Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system.
R. Jain (2000)
10.1248/YAKUSHI.127.1851
Application of a novel approach to prepare biodegradable polylactic-co-glycolic acid microspheres: surface liquid spraying.
H. Tang (2007)
10.1016/S0378-5173(00)00386-0
Relationship between polysorbate 80 solubilization descriptors and octanol-water partition coefficients of drugs.
F. Alvarez-Núñez (2000)
10.1016/0168-3659(85)90056-2
Preparation of injectable controlled-release microcapsules by a solvent-evaporation process
T. R. Tice (1985)
critical fluid precipitation technology. AAPS PharmSciTech 3 (article
T. R. Tice (1986)
Triamcinolone diacetate
K. lorey (1972)
Biodegradable Microparticle and In Situ Microparticle Systems
Xiaosong Luan (2006)
10.1081/e-ews2-120010187
Ph
李幼升 (1989)
10.1208/pt060475
Encapsulation of protein nanoparticles into uniform-sized microspheres formed in a spinning oil film
W. Leach (2008)
10.1080/026520400288319
Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system
R. A. Jain, C. T. Rhodes, A. M. Railkar, A. W. Mal (2000)
Microencapsulation of water - soluble medicaments
Y. Shi (2008)
10.1208/ps010307
A short-term (accelerated release) approach to evaluate peptide release from PLGA depot formulations
M. Shameem (2008)
[Lipoid pneumonia following attempted suicide by intravenous injection of lamp oil].
S. Perings (2001)
A physicochemical
V. August. osilio (1991)
Lipid injectable emulsions
D. F. iscoll (2006)
Prolonged release microcapsule and its production
H. kada (1987)
containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethyleneoxide
K. akino (2000)
Mikroverkapselung wasserlöslicher Wirkstoffe
R. Mank
Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals.
T. Chang (1976)
10.1016/J.ADDR.2007.05.007
High throughput solubility measurement in drug discovery and development.
J. Alsenz (2007)
10.1016/S0378-5173(01)00690-1
Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers.
R. Liggins (2001)
10.1023/A:1016419303727
The Preparation and Evaluation of Drug-Containing Poly(dl-lactide) Microspheres Formed by the Solvent Evaporation Method
R. Bodmeier (2004)
10.1016/S0939-6411(00)00079-5
Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination.
P. Johansen (2000)
10.1248/CPB.44.1935
Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol.
Y. Wang (1996)
Sustained release particles preparation
J. Ruiz (1991)
Polymeric delivery formulations of leuprolide with improved efficacy
L. R. unn (2003)
10.3109/02652049009028421
Microencapsulation using poly (L-lactic acid) II: Preparative variables affecting microcapsule properties.
R. Jalil (1990)
10.1002/JPS.2600731215
Characterization of drug-loaded poly(d,l-lactide) microspheres.
S. Benita (1984)
10.1016/j.clpt.2005.05.011
Transporters and drug therapy: Implications for drug disposition and disease
R. Ho (2005)
Vitamin preparations and methods of making same. US Patent 2,183,053
H. F. aylor (1938)
Controlled release of a luteinising hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres
L. M. anders (1984)
10.1016/J.BIOMATERIALS.2003.08.019
Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
J. Wang (2004)
Temperature effect on the water solubility and water-octanol partition of some steroids.
B. Lundberg (1979)
Sustained release formulation comprising
H. German. etersen (2007)
10.1016/0378-5173(88)90073-7
Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method
R. Bodmeier (1988)
Final position paper on the allergenic potency of herbal medicinal products containing soya or peanut proteins
Biodegradable polymers for controlled release of peptides and proteins.
F. G. Hutchinson (1989)
Eur., 2002a) and peanut oil
Ph (2002)
Gel compositions and methods. US Patent 6,130,200
K. J. rodbeck (2000)
10.1016/S0142-9612(02)00170-9
Why degradable polymers undergo surface erosion or bulk erosion.
F. von Burkersroda (2002)
Preparation of poly (llactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release
S. zumikawa (1991)
1987c. Poly(lactic acid) microspheres containing quinidine base and quinidine sulphate prepared by solvent evaporation technique
R. odmeier (1987)
Making microspheres using carboxylic acid salts as emulsifiers
J. W. ong (1981)
10.5860/choice.35-4499
Physical chemistry of surfaces
A. Adamson (1960)
Aqueous solubility of estrone, 17 -estradiol, 17 -ethinylestradiol, and bisphenol A
A. hareef (2006)
The biocompatibility and toxicity of degradable polymeric materials: implications for drug delivery
C. T. aurencin (1994)
10.1002/JBM.820250509
A physicochemical study of the morphology of progesterone-loaded microspheres fabricated from poly(D,L-lactide-co-glycolide).
V. Rosilio (1991)
Mathematical modeling and optimization of drug delivery from intratumorally injected microspheres.
A. Tzafriri (2005)
Protein behaviour at the water methylene chloride
H. ah (1999)
Sustained release particles preparation. UK Patent Application Publication GB
J.-M Ruiz
Microsphere morphology
J. P. enoit (1996)
General Notices-Solubility. British Pharmacopoeia Commission, distributed by The Stationery Office Bookshop
(2001)
10.1021/JS9900654
Protein behavior at the water/methylene chloride interface.
H. Sah (1999)
10.1016/J.JCONREL.2006.02.004
Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
H. K. Kim (2006)
Role of efflux pumps and metabolizing enzymes in drug
S. atragadda (2005)
10.1002/MARC.200600531
Development of New Microencapsulation Techniques Useful for the Preparation of PLGA Microspheres
H. Sah (2006)
10.1163/156856206777346296
Effect of co-solvents on the characteristics of enkephalin microcapsules
R. Graves (2006)
10.1002/JPS.10524
Determination of water-soluble acid distribution in poly(lactide-co-glycolide).
A. G. Ding (2004)
10.1016/J.EJPB.2007.10.009
Myotoxicity studies of O/W-in situ forming microparticle systems.
W. Rungseevijitprapa (2008)
10.1007/978-0-387-72379-2_4
Drug Absorption Principles
X. Cao (2008)
10.1016/S0168-3659(02)00008-1
Biodegradable injectable in situ forming drug delivery systems.
A. Hatefi (2002)
10.1248/cpb.30.3719
Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine.
N. Wakiyama (1982)
Betamethasone diproprionate
M. G. errante (1977)
WIRKSAMKEIT UND VERTRAGLICHKEIT VON 2 APPLIKATIONSFORMEN (S.C. UND I.M.) VON DECAPEPTYL DEPOT BEI PATIENTEN MIT FORTGESCHRITTENEM PROSTATAKARZINOM
K. F. Klippel (1999)
10.1111/j.2042-7158.1986.tb04561.x
The formation and characterization of hydrocortisone‐loaded poly((±)‐lactide) microspheres
M. Cavalier (1986)
Monthly microcapsule - depot form of LHRH agonist , leuprolide acetate ( Enantone ® Depot ) : formulation and pharmacokinetics in animals
M. Singh (1992)
Supercritical fluid extraction in plant
S. M. 1089–1090. ourmortazavi (2007)
Preparation of extended shelf - life biodegradable , biocompatible microparticles containing a biologically active agent
V. osilio (1998)
10.1248/CPB.36.1095
A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid.
Y. Ogawa (1988)
10.3109/02652048709021820
Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology.
R. Bodmeier (1987)
Molecular and biochemical aspects impacting oral absorption of drugs
R. Krishna (2008)
Degradable polymers for sustained drug release
S. olles (1980)
Teilchengrößenmessung in der Laborpraxis. Wissenschaftliche Verlagsgesellschaft
R H Müller (1996)
10.1016/S1056-8719(00)00107-6
Drug-like properties and the causes of poor solubility and poor permeability.
C. Lipinski (2000)
10.1112/PLMS/S1-10.1.4
On The Instability Of Jets
L. Rayleigh (1878)
10.1016/0002-9378(81)90743-2
Clinical evaluation of injectable biodegradable contraceptive system.
L. Beck (1981)
10.3109/02652049109021231
Use of polylactic acid for the preparation of microparticulate drug delivery systems.
B. Conti (1992)
Vitamin preparations and methods of making same
S. L. aylor (1938)
Biodegradable in-situ forming implants and methods of producing the same
L. R. unn (1994)
10.1023/A:1007582911958
Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres
K. Fu (2004)
10.1016/S0169-409X(97)00050-1
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate.
Okada (1997)
10.1080/02652040701233655
Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles
Saowanee Jaraswekin (2007)
Three - month release injectable microspheres of leuprolin acetate
Y. Ionoue (1992)
10.1080/03639040500217624
Biodegradable Microparticulates of Beta-Estradiol: Preparation and In Vitro Characterization
A. Zaghloul (2005)
10.1007/BF01849415
Preparation and pharmacokinetic evaluation of a modified long-acting injectable norethisterone microsphere
H. Cong (1991)
10.1016/0378-5173(86)90081-5
Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration
A. Smith (1986)
10.3109/02652049309015325
Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.
F. Pavanetto (1993)
10.1073/PNAS.81.18.5845
Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.
T. Redding (1984)
Solid - state solubility influences encapsulation efficiency and release of hydrophobic drugs from PLGA / PLA nanoparticles
B. V. arikh (2004)
10.1002/JPS.2600740106
Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(d,l-lactide).
K. Suzuki (1985)
10.1007/BF02830616
Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology
T. Martin (2008)
Biodegradable in-situ forming implants and methods of producing the same. US Patent 4,938,763
L. R. unn (1990)
A brief history of droplet formation
J. ggers (2006)
Monthly microcapsule-depot form of LHRH agonist, leuprolide acetate (Enantone® Depot): formulation and pharmacokinetics in animals
Y. gawa (1992)
Microencapsulation process. US Patent 4
T R Tice
Sustained drug delivery
C. G. itt (1979)
10.1038/clpt.1984.243
Kinetics of a naltrexone sustained‐release preparation
C. Chiang (1984)
10.1016/0091-6749(92)90461-A
Allergenicity of peanut and soybean extracts altered by chemical or thermal denaturation in patients with atopic dermatitis and positive food challenges.
A. Burks (1992)
10.1016/S0168-3659(03)00194-9
Biodegradable microspheres for protein delivery.
V. Sinha (2003)
10.1016/S1081-1206(10)61181-7
Sesame allergy: a growing food allergy of global proportions?
Venu Gangur (2005)
10.1016/S0168-3659(03)00366-3
Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry.
D. Na (2003)
A microcapsule system for drug delivery
E. S. uwayser (1977)
Monthly microcapsule-depot form of LHRH agonist, leuprolide
Y. 439–444. gawa (1992)
Pathways of inactivation of tetanus toxoid in the presence of PLA
S. P. chwendeman (1995)
Gel compositions and methods
ゲイナー−ドアーテ,アン,ティ. (1997)
Poly(lactic acid) microspheres containing quinidine base and quinidine sulphate prepared by solvent evaporation technique. II. Some process parameters influencing the properties of microspheres
R. odmeier (1987)
10.1016/0168-3659(95)00070-O
Preparation and degradation of surfactant-free PLAGA microspheres
A. Carrió (1995)
10.1016/0168-3659(91)90028-C
Parenteral depot-systems on the basis of biodegradable polyesters
T. Kissel (1991)
10.1007/s11095-004-1871-1
Intravenous Hydrophobic Drug Delivery: A Porous Particle Formulation of Paclitaxel (AI-850)
J. A. Straub (2004)
10.1021/JS980169Z
Mechanisms of solvent evaporation encapsulation processes: prediction of solvent evaporation rate.
J. Wang (1999)
10.1002/JBM.820050305
Biodegradable poly(lactic acid) polymers.
R. K. Kulkarni (1971)
10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids.
S. Li (1999)
10.1016/S1369-7021(05)71036-1
Drug delivery goes supercritical
P. Ginty (2005)
10.1042/BST0130520
Biodegradable polymers for the sustained release of peptides.
F. G. Hutchinson (1985)
10.1016/S0142-9612(00)00115-0
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
R. Jain (2000)
10.1016/J.ADDR.2007.05.011
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
N. Blagden (2007)
10.1016/S0168-3659(96)01469-1
In vitro evaluation of the hydrolytic degradation of dispersed and aggregated poly(dl-lactide-co-glycolide) microspheres
P. Sansdrap (1997)
10.1016/J.JCONREL.2004.12.023
Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
L. Mu (2005)
Computational approaches to predict solubility
B. aller (2007)
10.1023/A:1018876308346
The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins
A. Shenderova (2004)
10.1002/JPS.2600640239
Long acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) composites.
S. Yolles (1975)
10.1021/BM700870X
Ammonolysis-induced solvent removal: a facile approach for solidifying emulsion droplets into PLGA microspheres.
J. Kim (2007)
10.1016/J.JCONREL.2004.10.019
Controlled release from bioerodible polymers: effect of drug type and polymer composition.
Alexis Frank (2005)
10.1016/S0378-5173(99)00379-8
Ethyl formate - alternative dispersed solvent useful in preparing PLGA microspheres.
H. Sah (2000)
10.1208/pt0802037
Ketoprofen poly(lactide-co-glycolide) physical interaction
P. Blasi (2008)
10.1016/S0076-6879(85)12010-0
Poly(lactide-co-glycolide) microcapsules for controlled release of steroids.
D. Cowsar (1985)
10.1080/10837450600770478
Response Surface Methodology to Obtain β-Estradiol Biodegradable Microspheres for Long-Term Therapy of Osteoporosis
A. Zaghloul (2006)
Development of microencapsulated norgestimate as a long-acting contraceptive.
Hahn Dw (1984)
Drug Delivery Systems. US Department of Health, Education, and Welfare
E S Nuwayser (1977)
Polylactic acid microspheres and process for producing the same. US Patent 4,994,281
S. uranishi (1991)
Biodegradable microspheres for prolonged local anesthesia
M. akano (1984)
essential and volatile oil analysis
G. afler (1997)
initial burst and the pulsatile release of drugs? Colloids Surf
R. ank (1996)
10.1016/S0169-409X(97)00048-3
Biodegradation and biocompatibility of PLA and PLGA microspheres
J. Anderson (1997)
10.1016/S0168-3659(98)00085-6
The application of microspheres from the copolymers of lactide and ϵ-caprolactone to the controlled release of steroids
B. Buntner (1998)
Kinetics of a naltrexone sustained release formulation
C N Chiang (1984)
Bioresorbable polymer microspheres free from surface active agents , their preparation and application as drug
F. Burkersroda (2006)
Influence of polymeric
Immunol (2003)
10.1016/S0010-7824(76)80047-9
An injectable sustained release fertility control system.
L. Anderson (1976)
Phase separation-microencapsulated pharmaceuticals compositions useful for alleviating dental disease
로늘드 로터 제임스 (1988)
10.1016/J.ADDR.2004.09.002
Formulation aspects of biodegradable polymeric microspheres for antigen delivery.
H. Tamber (2005)
10.1002/3527604812.CH6
Applications of Surfactants in Emulsion Formation and Stabilisation
T. Tadros (2005)
10.1016/0142-9612(94)90196-1
Piroxicam release from spray-dried biodegradable microspheres.
B. Wagenaar (1994)
10.1016/0168-3659(88)90022-3
Pyrimethamine sustained release systems based on bioresorbable polyesters for chemoprophylaxis of rodent malaria
M. Tsakala (1987)
10.1016/S0928-0987(99)00079-2
A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids.
R. Ghaderi (2000)
10.1016/S0168-3659(97)00188-0
Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
C. Witschi (1998)
10.1016/J.EJPB.2007.06.008
Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
S. Mao (2008)
Pathways of inactivation of tetanus toxoid in the presence of PLA 2000
S. P. chwendeman (1995)
Pharmaceutical composition comprising microparticles. International Patent Application Publication WO
O Lambert
Preparation and evaluation in vitro and in vivo of copoly(lactic/glycoli) acid microspeheres containing norethisterone
Z. hifang (1993)
Pharmacopoeia Europea) 4, 2002c. Triglycerides, Medium-chain
Ph
Solubility in % (m/m) at 20 ◦C (methylene chloride: 25 ◦C) and boiling point according to Doolittle
Sah (1954)
10.1007/s11095-004-1195-1
Preparation of Microparticles by Micromixers: Characterization of Oil/Water Process and Prediction of Particle Size
Kathrin Schalper (2004)
10.3109/02652049309104380
Oestrone loaded poly(l-lactic acid) microspheres: preparation, evaluation and in vitro release kinetics.
B. V. Parikh (1993)
Verfahren zur in-situ Herstellung von Partikeln. German Patent Application Publication DE
R Bodmeier
A biodegradable, injectable delivery system for nonsteroidal anti-inflammatory drugs
A. J. ipton (1991)
Medical applications of intramuscularly
I. Lancranjan (1993)
10.1016/J.IJPHARM.2005.07.028
Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization.
K. Elkharraz (2006)
Drug Delivery Systems. US Department of Health, Education, and Welfare
D L Gardner (1977)
10.1016/0142-9612(96)81421-9
In vitro biocompatibility of bioresorbable polymers: poly(L, DL-lactide) and poly(L-lactide-co-glycolide).
A. Ignatius (1996)
10.1016/S0927-7765(03)00152-8
Influence of polymeric surfactants on the properties of drug-loaded PLA nanospheres
C. Rouzes (2003)
Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals.
Chang Tm (1976)
Polyolester, deren Herstellung und Verwendung
B. denek (1989)
Guidance for Industry. Q3B(R2) Impurities in new drug products
Ich Q3b Guidance (2006)
Teilchengrößenmessung in der Laborpraxis
R. H. 565–575. üller (1996)
10.1542/peds.2007-0350
Clinical Characteristics of Peanut-Allergic Children: Recent Changes
Todd D. Green (2007)
Pharmacopoeia Europea) 4, 2002a. Parenteral Preparations. European Pharmacopoeia Commission
Ph
1988c. In vivo release
Chem. Pharm. Bull (1988)
Microencapsulation of water soluble polypeptides
J. S. ent (1986)
10.1248/CPB.36.1502
Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer.
Y. Ogawa (1988)
10.1163/156856204323005343
Aqueous N,N-diethylnicotinamide (DENA) solution as a medium for accelerated release study of paclitaxel
Namjin Baek (2004)
10.1081/PDT-100100535
Comparison of Various Injectable Protein-Loaded Biodegradable Poly(Lactide-co-glycolide) (PLGA) Devices: In-Situ-Formed Implant Versus In-Situ-Formed Microspheres Versus Isolated Microspheres
R. Jain (2000)
10.1023/A:1011939607573
Monitoring Microviscosity and Microacidity of the Albumin Microenvironment Inside Degrading Microparticles from Poly(lactide-co-glycolide) (PLG) or ABA-triblock Polymers Containing Hydrophobic Poly(lactide-co-glycolide) A Blocks and Hydrophilic Poly(ethyleneoxide) B Blocks
K. Mäder (2004)
Biodegradable microspheres: Advances in production technology
J. Benoît (1996)
10.1016/S0168-3659(96)01508-8
Controlled release of ionic compounds from poly (l-lactide) microspheres produced by precipitation with a compressed antisolvent
R. F. Falk (1997)
10.1016/J.IJPHARM.2003.08.011
Preparation and characterization of injectable microspheres of contraceptive hormones.
Magharla Dasaratha Dhanaraju (2003)
10.1006/JCIS.1995.1047
Dynamic Properties of Poly(DL-lactide) and Polyvinyl Alcohol Monolayers at the Air/Water and Dichloromethane/Water Interfaces
F. Boury (1995)
10.1016/0378-5173(89)90068-9
The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systems
R. Bodmeier (1989)
10.1023/A:1015879400962
In Vivo Evaluation of Biodegradable Progesterone Microspheres in Mares
P. Gupta (2004)
Enzyme-catalyzed processes of firstpass hepatic and intestinal drug
K. E. hummel (1997)
Stability and release kinetics of drugs incorporated within microspheres
J. P. enoit (1984)
Preparation , characterization , and drug delivery application of microspheres based biodegradable lactic / glycolic acid polymers
D. Wise
Pharmaceutical aspects. Nasal and depot formulations of leuprolide.
T. Shimamoto (1987)
10.1016/S0939-6411(97)00152-5
Ultrasound-induced degradation of PLA and PLGA during microsphere processing: influence of formulation variables.
G. Reich (1998)
10.1016/j.ddtec.2004.11.007
Lead- and drug-like compounds: the rule-of-five revolution.
C. Lipinski (2004)
10.3109/02652048909031167
Microencapsulation using poly(L-lactic acid). I: Microcapsule properties affected by the preparative technique.
R. Jalil (1989)
10.1016/J.JCONREL.2005.07.009
Plasticizing effect of water on poly(lactide-co-glycolide).
P. Blasi (2005)
Injizierbares Implantat
M Dittgen
10.1016/0168-3659(94)00083-7
Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins
W. J. Lambert (1995)
A physico-chemical study of the morphology of progesterone-loaded 85:15 poly(d,l-lactide-co-glycolide) microspheres
J. P. enoit (1986)
Sustained - release composition andmethod for preparing the same
M. ellet (2001)
10.1016/0030-4220(71)90265-9
Histologic comparison of polylactic and polyglycolic acid sutures.
D. E. Cutright (1971)
Sustained release formulations of water soluble peptides and process for preparing same
보드머데이비드 (1999)
10.1016/0378-5173(86)90106-7
A physicochemical study of the morphology of progesterone-loaded poly (d,l-lactide) microspheres
J. Benoît (1986)
10.1016/J.IJPHARM.2006.09.033
A novel in situ forming drug delivery system for controlled parenteral drug delivery.
H. Kranz (2007)
10.1016/0168-3659(94)90159-7
Drug delivery using biodegradable microspheres
Okada Hiroaki (1994)
10.1080/10611860310001648248
Classification Analysis of P-Glycoprotein Substrate Specificity
R. Didziapetris (2003)
10.1016/S0927-7765(00)00148-X
Pulsatile drug release from poly (lactide-co-glycolide) microspheres: how does the composition of the polymer matrices affect the time interval between the initial burst and the pulsatile release of drugs?
K. Makino (2000)
Medication noncompliance in schizophrenia: codification and update.
J. L. Young (1986)
10.1016/J.JCONREL.2003.08.015
Controlled release of estradiol solubilized in carbopol/surfactant aggregates.
R. Barreiro-Iglesias (2003)
10.1016/J.CHROMA.2007.06.021
Supercritical fluid extraction in plant essential and volatile oil analysis.
S. M. Pourmortazavi (2007)
Biodegradable in situ forming systems and sponge-like implants
V. Voigt (2006)
Microencapsulation process
D. H. Lewis (1983)
Formation of biodegradable drug-loaded microparticles by in-liquid drying processes. In: Donbrow, M. (Ed.), Microcapsules and Nanoparticles in Medicine and Pharmacy
C. hies (1991)
Emulsification: more than just communication
H. P. chuchmann (2004)
10.1007/PL00002161
Entwicklung einer lipoiden Pneumonie als Folge einer intravenösen Injektion von Lampenöl in suizidaler Absicht
S. Perings (2001)
10.1248/CPB.37.802
Targeted and sustained delivery of aclarubicin to lymphatics by lactic acid-oligomer microsphere in rat.
H. Yoshikawa (1989)
10.1016/0378-5173(91)90314-E
The preparation and characterisation of poly(lactide-co-glycolide) microparticles. I: Oil-in-water emulsion solvent evaporation
H. Jeffery (1991)
10.3109/02652049309015322
Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
J. Lalla (1993)
Pathways of inactivation of tetanus toxoid in the presence of PLA 2000. Presentation at the AAPS meeting
S P Schwendeman (1995)
United States Pharmacopoeia)-in-process revision
(2006)
Standard dialysis tubing with a 12–14 kDa
Yang (1997)
Mikroverkapselung wasserlöslicher Wirkstoffe
B. erlich (1996)
10.1023/A:1026464124412
Biodegradable PLGA Microspheres Loaded with Ganciclovir for Intraocular Administration. Encapsulation Technique, in Vitro Release Profiles, and Sterilization Process
R. Herrero-Vanrell (2004)
10.1016/0378-5173(93)90052-H
Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-glycolide) microspheres
P. Sansdrap (1992)
10.1517/17425247.2.4.683
Role of efflux pumps and metabolising enzymes in drug delivery
Suresh Katragadda (2005)
10.1016/0168-3659(95)00076-3
Prediction of solvent removal profile and effect on properties for peptide-loaded PLGA microspheres prepared by solvent extraction/ evaporation method
Wen-I Li (1995)
Sustained release compositions and process for their preparation
Marc Pellet (1998)
Steroid release from microcapsules.
D. Gardner (1977)
10.1016/0168-3659(95)00026-5
Microencapsulation by coacervation of poly(lactide-co-glycolide). IV. Effect of the processing parameters on coacervation and encapsulation
Nicole Nihant (1995)
10.1016/S0896-8446(01)00064-X
Particle design using supercritical fluids: Literature and patent survey
Jennifer Jung (2001)
10.1002/CITE.330550804
Elementarprozesse bei der Herstellung und Stabilisierung von Emulsionen
R. Heusch (1983)
10.1021/bp9701271
Development and Scale‐up of a Microsphere Protein Delivery System
M. Tracy (1998)
10.1016/S0168-3659(99)00122-4
Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin.
B. Ertl (1999)
Halogenated Hydrocarbones. Marcel Dekker
A L Horvath (1982)
10.3109/02652048609031571
Kinetics of drug release from polylactic acid-hydrocortisone microcapsules.
N. Leelarasamee (1986)
10.1201/9780849350610
Injectable dispersed systems : formulation, processing, and performance
D. Burgess (2005)
Biodegradable polymeric microparticles with “open/closed” pores for sustained release of human growth hormone
H. K. im (2006)
Analysis may also include prediction f likely degradants from organic chemistry
al (2006)
10.1016/J.EJPS.2005.09.002
In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters.
Xiaosong Luan (2006)
High viscosity liquid controlled delivery system as a device. US Patent 5,968,542
A. J. ipton (1999)
10.1002/JBM.820130313
Sustained drug delivery systems. I. The permeability of poly(ϵ-caprolactone), poly(DL-lactic acid), and their copolymers
C. Pitt (1979)
10.3109/02652049009028423
Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone.
R. Jalil (1990)
10.1016/S0142-9612(00)00080-6
Paclitaxel loaded poly(L-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill.
R. Liggins (2000)
10.1016/S0168-3659(01)00440-0
Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers.
L. Mu (2001)
10.1016/0040-6031(94)01947-F
Thermoanalysis of microspheres
C. Dubernet (1995)
10.1016/J.EJPB.2006.06.009
Effect of drug type on the degradation rate of PLGA matrices.
S. Siegel (2006)
Depot neuroleptic therapy: clinical considerations.
Remington Gj (1995)
10.1016/0002-9378(79)90717-8
New long-acting injectable microcapsule contraceptive system.
L. Beck (1979)
10.1002/JPS.2600730927
Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres.
L. M. Sanders (1984)
10.1016/S0168-3659(97)00082-5
In vitro and in vivo evaluation of taxol release from poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres
Y. Wang (1997)
Amicrocapsule system for drug delivery
E. S. uwayser
Verfahren zur in-situ Herstellung von Partikeln
R. odmeier (1998)
10.1021/bp9600492
Microencapsulation of Naproxen Using Rapid Expansion of Supercritical Solutions
Jonghyun Kim (1996)
10.3109/02652049809006870
Clonazepam microencapsulation in poly-D,L-lactide-co-glycolide microspheres.
P. Benelli (1998)
10.1016/S0002-9610(97)00079-2
The development of a novel intraperitoneal tumor-seeding prophylactic.
J. Demetrick (1997)
10.1016/S0168-3659(02)00136-0
Precise control of PLG microsphere size provides enhanced control of drug release rate.
C. Berkland (2002)
10.1007/s001200050280
Efficacy and tolerability of 2 application forms (s. c. and i. m.) of decapeptyl® depot in patients with advanced prostate cancer
K. F. Klippel (1999)
10.1021/JM020017N
Molecular properties that influence the oral bioavailability of drug candidates.
D. Veber (2002)
Very low temperature casting of controlled release microspheres
W. R. ombotz (1991)
Prolonged release microcapsule and its pro
H. pp. 147–172. kada (1987)
10.1016/0002-9378(83)90046-7
Clinical evaluation of an improved injectable microcapsule contraceptive system.
L. Beck (1983)
10.1016/S0939-6411(00)00062-X
Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables.
R. Jain (2000)
10.1016/0168-3659(92)90112-5
Biodegradable block copolymer matrices for long-acting contraceptives with constant release.
Gu Zhong-wei (1992)
10.1016/S0378-5173(96)04810-7
Physico-chemical parameters governing protein microencapsulation into biodegradable polyesters by coacervation
C. Thomasin (1997)
10.1016/j.addr.2012.09.004
Biodegradation and biocompatibility of PLA and PLGA microspheres.
Shive (1997)
10.1080/02652040400015387
The mechanism of surface-indented protein-loaded PLGA microparticle formation: the effects of salt (NaCl) on the solidification process
J. L. Chen (2004)
10.1016/S0142-9612(00)00040-5
Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles.
M. Dunne (2000)
10.1002/JPS.2600701115
Theoretical comparison of release rates of drugs into sink and nonsink conditions.
R. H. Guy (1981)
Evaluation of a new three-month injectable contraceptive microsphere system in primates (baboon)
L. R. eck (1980)
Polylactic acid microspheres
S. Stuttgart. uranishi (1991)
Solubility of sparingly-soluble drugs
A. vdeef (2007)
Continuous release pharmaceutical compositions
F. G. utchinson (1986)
10.1016/S0378-5173(01)00968-1
Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles.
H. Choi (2002)
10.1016/J.IJPHARM.2007.01.038
Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Kumar G. Janoria (2007)
10.1016/J.POLYMER.2006.01.021
Hydrolytic degradation of poly(d,l-lactide) as a function of end group: Carboxylic acid vs. hydroxyl
Jeffrey S. Wiggins (2006)
10.1023/A:1014272816454
Peptide Acylation by Poly(α-Hydroxy Esters)
A. Lucke (2004)
Process for encapsulatingwater and compounds in aqueous phase by extraction
R. ada (1988)
10.1016/S0169-409X(00)00129-0
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
C. Lipinski (1997)
CONTROLLED RELEASE SYSTEMS OF BIODEGRADABLE POLYMERS : 6TH COMMUNICATION :CONTROL OF PARTICLE SIZE AND SIZE DISTRIBUTION OF MICROPARTICLES PRODUCED B Y THE SOLVENT EVAPORATION TECHNIQUE
M. Jobmann (1998)
10.1021/JA055287K
Prediction of microclimate pH in poly(lactic-co-glycolic acid) films.
A. G. Ding (2006)
Apparatus and method for preparing microparticles
ライオンズ,ショーン,エル. (2000)
10.1111/j.2042-7158.1989.tb06398.x
Solubilization of Indomethacin by Polysorbate 80 in Mixed Water‐Sorbitol Solvents
D. Attwood (1989)
10.1016/0168-3659(86)90071-4
Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament
H. V. Maulding (1986)
10.1007/978-1-59259-427-6_6
Microparticle Drug Delivery Systems
D. Birnbaum (2004)
10.1248/CPB.36.2576
In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers.
Y. Ogawa (1988)
Sustained-release composition and method for its preparing
Казумити Ямамото (2002)
10.1016/j.jconrel.2005.10.005
Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
Xiaosong Luan (2006)
10.1021/JE050318C
Aqueous Solubilities of Estrone, 17-Estradiol, 17a-Ethynylestradiol, and Bisphenol A
A. Shareef (2006)
10.1016/0003-2670(91)90042-4
Analytical profiles of drug substances
K. Florey (1972)
10.1038/nm0796-795
A month–long effect from a single injection of microencapsulated human growth hormone
O. Johnson (1996)
10.1016/S0168-3659(01)00276-0
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs.
G. Zentner (2001)
10.1201/9781003067542-1
STABILITY OF PROTEINS AND THEIR DELIVERY FROM BIODEGRADABLE POLYMER MICROSPHERES
S. Schwendeman (1996)
10.1016/S0168-3659(03)00128-7
Modeling and analysis of dispersed-drug release into a finite medium from sphere ensembles with a boundary layer.
Y. Zhou (2003)
10.1016/S0168-3659(02)00137-2
Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
J. Wang (2002)
10.1016/0142-9612(94)90032-9
Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cells and their effects on the biocompatibility, in vivo.
S. A. Ali (1994)
10.1016/J.ADDR.2007.02.003
Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas.
K. Mishima (2008)
Method and apparatus for preparing microparticles using in-line solvent extraction. US Patent 6,939,033
S. L. yons (2005)
10.1016/0378-5173(94)90278-X
Influence of gas density and pressure on microparticles produced with the ASES process
J. Bleich (1994)
10.1023/A:1012172722246
Stabilization of 10-Hydroxycamptothecin in Poly(lactide-co-glycolide) Microsphere Delivery Vehicles
A. Shenderova (2004)
mers. 6th communication: control of particle size and size distribution of microparticles produced by the solvent evaporation technique
P. ohanson (2000)
Polylactide–drug mixtures. US Patent 3,773,919
G. A. oswell (1973)
Biodegradable microspheres for prolonged local anesthesia
M Nakano (1984)
In vitro and in vivo properties of injectable biodegradable in situ forming microparticle systems
W. m-Emsap (2002)
Pharmaceutical composition comprising microparticles
O. ambert (2004)
10.1016/J.JCONREL.2004.07.029
Mapping neutral microclimate pH in PLGA microspheres.
Lei Li (2005)
10.1016/0378-5173(95)04106-0
Somatostatin containing biodegradable microspheres prepared by a modified solvent evaporation method based on W/O/W-multiple emulsions
J. Herrmann (1995)
10.1177/088391158800300203
Lactic Acid Oligomer Microspheres Containing an Anticancer Agent for Selective Lymphatic Delivery: I. In Vitro Studies
R. Wada (1988)
10.1021/MP060041N
Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins.
Jichao Kang (2007)
10.1016/S0168-3659(01)00289-9
Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions.
C. Berkland (2001)
10.3109/02652049809006848
PDLLA microspheres containing steroids: spray-drying, o/w and w/o/w emulsifications as preparation methods.
P. Giunchedi (1998)
10.1016/0168-3659(89)90047-3
The acceleration of degradation-controlled drug delivery from polyester microspheres
Y. Cha (1989)
10.1016/J.IJPHARM.2005.05.038
Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies.
S. Wang (2005)
10.1016/0168-3659(86)90030-1
Controlled release of aclarubicim, an anticancer antibiotic, from poly-β-hydroxybutyric acid microspheres
Juni Kazuhiko (1986)
10.2741/1559
The preclinical development of Medisorb Naltrexone, a once a month long acting injection, for the treatment of alcohol dependence.
R. Dean (2005)
10.1007/0-387-29195-4
Nonsmooth Mechanics and Analysis
P. Alart (2006)
10.1023/A:1015887919560
Opioid-Induced Respiratory Depression and Analgesia May Be Mediated by Different Subreceptors
E. Freye (2004)
Controlled release
Pharm. Bull (1989)
Microencapsulated 3 - Piperidinyl - substituted 1 , 2 - benzisooxazoles and 1 , 2 - benzisothiazoles . US Patent 6 , 544 , 559 ( 8 April )
J. esens (2006)
Chemical Hazards Response Information System . Methyl dichloroacetate datasheet
A. A. an Apeldoorn
Processes for preparation of microspheres
J. W. ong (1979)
10.1177/070674379504003s02
Depot neuroleptic therapy: clinical considerations.
G. Remington (1995)
Multiphase system. International Publication WO
R. odmeier (1998)
Medical applications of intramuscularly administered bromocriptin microspheres
M. ontini (1993)
10.1586/14760584.2.2.269
Microparticles as vaccine adjuvants and delivery systems
D. O'hagan (2003)
10.1016/0091-6749(81)90135-4
Peanut oil is not allergenic to peanut-sensitive individuals.
S. Taylor (1981)
10.1081/DDC-100100328
Biodegradable Progesterone Microsphere Delivery System for Osteoporosis Therapy
Q. Yang (2000)
10.3109/02652049609052902
Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process.
J. Bleich (1996)
10.1016/J.SUPFLU.2004.05.002
Solubility of some inhaled glucocorticoids in supercritical carbon dioxide
A. Vatanara (2005)
10.1002/JPS.2600791016
Lactic acid oligomer microspheres containing hydrophilic drugs.
R. Wada (1990)
Polylactide-drug mixtures
G A Boswell
Microsphere: design and manufacturing
D. J. urgess (2005)
ike numerous traditionally used solvents for encapsulation, are oxic
ethyl chloroacetate Pohanish (1996)
Preparation of extended
tions. Can. J. Psychiat (1998)
10.1016/S0168-3659(98)00061-3
Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy.
T. Zhou (1998)
10.1095/BIOLREPROD28.1.186
Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive.
L. Beck (1983)
Pharmaceutical composition in the form of microparticles
C. B. ackhaeuser (1993)
Method for preparing a pharmaceutical composition in the form of microparticles
P. rsolini (1992)
Medical applications of intramuscularly administered bromocriptin microspheres
A. Rolland (2001)
Steroid drugs are an important class of poorly water
(2001)
Three-month release injectable
C. Wischke (1992)
10.1016/S0168-3659(99)00219-9
Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.
D. Birnbaum (2000)
Chemical Hazards Response Information System
10.1002/JPS.2600561005
Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms.
M. Gibaldi (1967)
10.1002/CBER.19270600733
Über den oly‐vinylalkohol
Willy O Herrmann (1927)
10.1159/000072135
Tree Nut Allergens
K. Roux (2003)
10.1016/J.IJPHARM.2005.06.029
New drug salt formation in biodegradable microspheres.
Ahmad Al-Maaieh (2005)
10.32388/i2tar4
The phase II trial.
R. Wittes (1985)
10.1016/J.EJPB.2005.08.015
Preparation of protein loaded poly(D,L-lactide-co-glycolide) microparticles for the antigen delivery to dendritic cells using a static micromixer.
C. Wischke (2006)
10.1016/0010-7824(78)90017-3
Larger animal testing of an injectable sustained release fertility control system.
J. Gresser (1978)
10.1081/DDC-43985
Reduction in the Initial-Burst Release by Surface Crosslinking of PLGA Microparticles Containing Hydrophilic or Hydrophobic Drugs
A. Thote (2005)
10.1016/J.JACI.2007.07.027
The natural history of peanut allergy: Extending our knowledge beyond childhood.
J. Savage (2007)
10.1248/CPB.33.313
Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin.
K. Juni (1985)
10.1016/J.ADDR.2006.10.006
The role of degradant profiling in active pharmaceutical ingredients and drug products.
Karen M. Alsante (2007)
10.1023/A:1015274031704
A phase II trial with new triptorelin sustained release formulations in prostatic carcinoma
N. Minkov (2004)
10.1016/S0939-6411(97)00125-2
Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods.
J. Herrmann (1998)
In vitro evaluation of taxol release from poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of microspheres
Y. M. ang (1997)
10.1016/0168-3659(95)00138-7
Hydrolytic degradation of poly(DL-lactic acid) in the presence of caffeine base
S. Li (1996)
10.1248/CPB.29.3363
Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics.
N. Wakiyama (1981)
10.1016/0168-3659(90)90167-R
A new method for the preparation of drug containing polylactic acid microparticles without using organic solvents
B. Wichert (1990)
10.1208/pt040101
Synergistic effect of PEG-400 and cyclodextrin to enhance solubility of progesterone
I. Nandi (2008)
10.1016/J.ADDR.2006.12.001
Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering.
O. R. Davies (2008)
10.1016/J.ADDR.2007.05.008
Solubility of sparingly-soluble ionizable drugs.
A. Avdeef (2007)
10.1016/S0927-7765(99)00105-8
Sustained release of 17β-estradiol from poly (lactide-co-glycolide) microspheres in vitro and in vivo
Takao Mogi (2000)
10.1007/s11606-007-0280-7
Not Your Typical Pneumonia: A Case of Exogenous Lipoid Pneumonia
A. Simmons (2007)
10.1002/JPS.20094
Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles.
J. Panyam (2004)
10.1016/0168-3659(93)90217-S
A biodegradable injectable implant for delivering micro and macromolecules using poly (lactic-co-glycolic) acid (PLGA) copolymers
N. Shah (1993)
10.1002/JPS.20555
Drug encapsulation using supercritical fluid extraction of emulsions.
P. Chattopadhyay (2006)
10.1021/JA0459936
Raman imaging of PLGA microsphere degradation inside macrophages.
A. V. van Apeldoorn (2004)
10.1021/JS960480L
Factors affecting the in vitro release of recombinant human interferon‐γ (rhIFN‐γ) from PLGA microspheres
J. Yang (1997)
10.3109/02652048709021821
Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres.
R. Bodmeier (1987)
Synergistic effect of PEG-400
I. pp. 327–335. andi (2003)
The preparation and evaluation of drugcontaining poly(d,l-lactide) microspheres formed by the solvent evaporation method
R. odmeier (1987)
Method and apparatus for preparing microparticles using in - line solvent extraction
K. äder (2005)
10.1208/pt030318
Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology
T. Martin (2008)
Biodegradable low molecular weight tri - block poly ( lactid - co - glycolide ) polyethylene glycol copolymers having reverse thermal gelation properties
T. W. edding (2001)
In vito and in vivo evaluation of CCNU-loaded microspheres prepared from poly((±)-lactide) and poly( hydroxybutyrate)
issery (1984)
10.1248/CPB.30.2621
Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics.
N. Wakiyama (1982)
Sustained release compositions and the process
M. April. ellet (2002)
Controlled release systems of biodegradable polymers : 5th communication : Microparticle preparation by a salting-out process
G. Rafler (1997)
10.1016/J.IJPHARM.2007.10.030
PLGA-based drug delivery systems: importance of the type of drug and device geometry.
D. Klose (2008)
10.1016/S0169-409X(97)00039-2
Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction.
Shen (1997)
10.1007/s11095-007-9430-1
Formulation and Characterization of Injectable Poly(dl-lactide-co-glycolide) Implants Loaded with N-Acetylcysteine, a MMP Inhibitor
K. G. Desai (2007)
Making microspheres using carboxylic acid salts as emulsifiers. UK Patent Application Publication GB
J W Fong
10.1002/JPS.2600750805
Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization.
G. Spenlehauer (1986)
10.1002/(SICI)1097-4636(19990605)45:3<231::AID-JBM11>3.0.CO;2-H
Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys.
M. A. Royals (1999)
Elementary processes in the production and stabilization of emulsions
V. L. ill (1983)
Nifedipine-loaded PLGA microspheres: In vitro / in vivo comparison of drug release and polymer degradation
P. Sansdrap (1999)
10.1016/0168-3659(88)90082-X
A one-week subdermal delivery system for l-methadone based on biodegradable microcapsules
Ying Cha (1988)
Methods of preparing microparticles having a selected polymer molecular weight
ホッツ,ジョイス,エム. (2001)
10.1016/J.IJPHARM.2004.02.023
Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres.
A. Gupte (2004)
10.1016/J.CONTRACEPTION.2006.01.015
Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
M. Dhanaraju (2006)
10.1016/0304-3835(94)03614-O
Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid).
H. Burt (1995)
10.1007/BF00700871
Structure-property relationships in the case of the degradation of massive aliphatic poly-(α-hydroxy acids) in aqueous media
S. Li (1990)
Prolonged release microcapsule and its production
H Okada
Sustained release particle dispersion
R. odmeier (2002)
The effect of drug
M. 77–85. iyajima (1998)
10.1016/0142-9612(93)90151-Q
Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres.
P. Menei (1993)
10.1016/S0378-5173(99)00394-4
Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation.
M. Tunçay (2000)
Guidance for Industry. Q3C Impurities: Residual solvents
Ich Q3c Guidance (2003)
In vivo evaluation of biodegradable microspheres in mares
P. K. upta (1992)
10.1007/BF00700872
STRUCTURE – PROPERTY RELATIONSHIP IN THE CASE OF THE DEGRADATION OF MASSIVE ALIPHATIC POLY – (-HYDROXY ACIDS) IN AQUEOUS MEDIA, PART 1: DEGRADATION OF LACTIDE - GLYCOLIDE COPOLYMERS: PLA 37.5 GA 25 AND PLA 75 GA 25
S. Li (1990)
10.1021/JF071424G
Identification of a new natural Ara h 6 isoform and of its proteolytic product as major allergens in peanut.
H. Bernard (2007)
10.1016/J.JCONREL.2004.07.017
The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying.
M. Whitaker (2005)
Multiphase system
R Bodmeier
lactide-co-glycolide) microspheres formed by solvent evaporation method
T. M. artin (1993)
1972c. Triamcinolone acetonide
K. lorey (1972)
Stabilisation of 10Hydroxycamptpthecin in poly(lactide-co-glycolide) microsphere delivery
A. henderova (1997)
10.1016/S0142-9612(03)00419-8
Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.
G. Ruan (2003)
Progress and challenges for peptide, protein, and vaccine delivery from implantable polymeric systems
S. P. chwendeman (1997)
Pharmacopoeia Europea) 4, 2002b. Vegetable Fatty Oils
Ph
Synthesis and properties of biodegradable lactic/glycolic acid polymers
X S Wu (1995)
Polymorphic forms of naltrexone. International Publication WO
H. A. rittain (2004)
10.1081/DDC-43937
In Vitro Evaluation of Betamethasone-Loaded Nanoparticles
B. Arıca (2005)
United States Pharmacopoeia) 30, 2007. 1 Injections. US Pharmacopeial Convention
10.1002/JBM.820150604
The in-vitro degradation of poly(glycolic acid) sutures--effect of pH.
C. Chu (1981)
10.1016/0168-3659(95)00125-5
Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery
R. Jeyanthi (1996)
10.1097/CAD.0B013E328012BCCD
Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts
M. Xie (2007)
A six-month, open label, fixed dose study to evaluate the safety, tolerance, pharmacokinetics and endocrine efficacy of two doses of LA-2550 22.5 mg in patients with advanced prostate cancer
A. W. damson (1999)
copolymer composition. Biomaterials
F. avanetto (1993)
10.1002/JBM.820070204
Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat.
J. M. Brady (1973)
10.1208/pt050456
Stabilized nanoparticles of phytosterol by rapid expansion from supercritical solution into aqueous solution
M. Türk (2008)
10.1021/JS970048J
Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation.
C. Thomasin (1998)
10.1016/S0378-5173(02)00150-3
Jet milling--a new technique for microparticle preparation.
G. Nykamp (2002)
10.1016/0142-9612(95)93575-X
Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition.
T. Park (1995)
Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
홀거 페터센 (2006)
10.1023/A:1010167214806
Investigation of Progesterone Loaded Poly(D,L-Lactide) Microspheres Using TMDSC, SEM and PXRD
V. L. Hill (1998)
10.1016/J.ADDR.2007.04.012
Nanostructured lipid carriers (NLC) in cosmetic dermal products.
R. Mueller (2007)
10.1016/S0168-3659(97)01647-7
Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheres
H. Sah (1997)
10.1111/j.2042-7158.1988.tb05166.x
Preparation of Biodegradable Poly(±)lactide Microparticles Using a Spray‐Drying Technique
R. Bodmeier (1988)
Production of microspheres
N. akechi (2002)
Witschi and Doelker, 998), being the precondition for matrix degradation and drug elease
ater-uptake Hutchinson (1989)
wasserlöslicher Wirkstoffe. European Patent EP
N. April. ihant (1995)
High viscosity liquid controlled delivery system as a device
W.-Q. ong (1999)
Sustained release microsphere preparation containing antipsychotic drug and production process thereof
S. ino (1997)
thermal gelation properties. US Patent 6,201,072
T. W. March. edding (1984)
10.1016/J.ADDR.2006.10.004
Pharmaceutical impurities: analytical, toxicological and regulatory perspectives.
A. K. Basak (2007)
10.1385/MB:22:3:263
Supercritical fluids and their applications in biotechnology and related areas
J. Williams (2002)
10.1016/J.JACI.2007.07.015
Peanut allergy: emerging concepts and approaches for an apparent epidemic.
S. Sicherer (2007)
10.1111/j.2042-7158.1989.tb06497.x
Controlled Release of LHRH Agonist, Leuprolide Acetate, from Microcapsules: Serum Drug Level Profiles and Pharmacological Effects in Animals
Y. Ogawa (1989)
10.1007/BF01849793
Long-acting injectable microsphere formulation for the parenteral administration of levonorgestrel
L. Beck (1985)
10.1177/0115426506021004381
Lipid injectable emulsions: 2006.
D. Driscoll (2006)
10.1016/J.EJPB.2004.03.003
In situ forming parenteral drug delivery systems: an overview.
C. B. Packhaeuser (2004)
10.1016/S0142-9612(99)00002-2
Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro.
M. Tracy (1999)
Polylactic acidmicrospheres and process for producing the same
S. uranishi (1991)
Polymorphic forms of naltrexone
H A Brittain (2004)
10.3109/02652049009028422
Microencapsulation using poly (L-lactic acid) III: Effect of polymer molecular weight on the microcapsule properties.
R. Jalil (1990)
10.3109/03639049809082719
Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches.
R. Jain (1998)
10.1038/nrd2445
The influence of drug-like concepts on decision-making in medicinal chemistry
P. Leeson (2007)
Preparation of injectable suspensions having improved injectability
ザレ,スティーブン,イー. (2001)
10.1002/JPS.2600500506
Investigation of drug release from solids. IV. Influence of adsorption on the dissolution rate.
D. Wurster (1961)
10.1007/978-0-387-72379-2_10
Food Effects on Drug Bioavailability: Implications for New and Generic Drug Development
B. Davit (2008)
10.1016/0168-3659(86)90072-6
Evaluation of biodegradable microspheres prepared by a solvent evaporation process using sodium oleate as emulsifier
J. W. Fong (1986)
10.1023/A:1016080123176
A Novel Method of Preparing PLGA Microcapsules Utilizing Methylethyl Ketone
H. Sah (2004)



This paper is referenced by
10.1201/B19038-51
Emulsion-Solvent System for Drug Delivery
Wasfy M. Obeidat (2015)
Spray drying for the preparation of innovative nanocoatings and inhalable nanocarriers
Elias Baghdan (2018)
10.1039/C3TB20089B
Fluorescence imaging of cancer tissue based on metal-free polymeric nanoparticles - a review.
Antje Vollrath (2013)
PLGA-based micro- and nanoparticle development for chemically modified messenger RNA delivery
M. Utzinger (2017)
10.1016/j.jddst.2019.101327
In-vitro and in-vivo comparison of rSAG1-loaded PLGA prepared by encapsulation and adsorption methods as an efficient vaccine against Toxoplasma gondii”
Mojgan Allahyari (2020)
10.1007/s13346-010-0009-8
Intravitreal poly(l-lactide) microparticles sustain retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseases
N. B. Shelke (2010)
10.1016/j.ijpharm.2013.04.058
UPEC biomimickry at the urothelial barrier: lectin-functionalized PLGA microparticles for improved intravesical chemotherapy.
L. Neutsch (2013)
10.1007/s40204-020-00139-y
Recent advances in the formulation of PLGA microparticles for controlled drug delivery
Elena Lagreca (2020)
10.1016/j.jconrel.2019.05.039
Often neglected: PLGA/PLA swelling orchestrates drug release: HME implants.
C. Bode (2019)
10.1021/bm500410h
Imparting Superhydrophobicity to Biodegradable Poly(lactide-co-glycolide) Electrospun Meshes
Jonah A. Kaplan (2014)
10.1002/APP.33427
Biodegradable nanoparticles containing benzopsoralens : an attractive strategy for modifying vascular function in pathological skin disorders
A. Gomes (2011)
10.1016/J.APT.2016.02.007
Preparation of phylloquinone-loaded poly(lactic acid)/hydroxyapatite core–shell particles and their drug release behavior
F. Nagata (2016)
10.1016/j.foodchem.2017.07.144
Effect of nanoencapsulation using PLGA on antioxidant and antimicrobial activities of guabiroba fruit phenolic extract.
M. C. Pereira (2018)
10.1016/j.ejps.2010.09.008
PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Yolanda Parajó (2010)
10.1517/17425241003713486
Techniques for efficient entrapment of pharmaceuticals in biodegradable solid micro/nanoparticles
T. Ishihara (2010)
10.1039/C2JM31100C
Hybrid mesoporous gadolinium oxide nanorods: a platform for multimodal imaging and enhanced insoluble anticancer drug delivery with low systemic toxicity
Z. Liu (2012)
10.1007/s40005-013-0072-5
Drug release testing methods of polymeric particulate drug formulations
S. Amatya (2013)
Differentiation of embryonic stem cells through controlled release of growth factors from microspheres
eghosa omoregie andrew E A O olaye (2009)
Preparação e caracterização de sistemas de libertação controlada de fármacos com base em polímeros de origem natural
Patrícia Manuela Almeida Coimbra (2010)
Effect of various parameters on encapsulation efficiency of mPEG-PLGA nanoparticles: artificial neural network
Mohammad Malekpour (2018)
10.1016/j.ijpharm.2011.02.066
Development of mass transport resistance in poly(lactide-co-glycolide) films and particles--a mechanistic study.
S. Fredenberg (2011)
10.1101/538405
Synaptotagmin-1 and Doc2b exhibit distinct membrane remodeling mechanisms
R. Sorkin (2019)
10.1016/j.expneurol.2018.08.014
Matrices, scaffolds, and carriers for protein and molecule delivery in peripheral nerve regeneration
Kasra Tajdaran (2019)
10.1007/S11705-011-1141-9
Synthesis of depsipeptides from L-amino acids and lactones
Hongfei Cao (2011)
QUALITY BY DESIGN APPROACH TO OPTIMIZATION OF TACROLIMUS LOADED PLGA NANOPARTICLES
A. E. Shirsat (2015)
10.1002/smll.201703108
Nanocrystal-Polymer Particles: Extended Delivery Carriers for Osteoarthritis Treatment.
P. Maudens (2018)
10.1002/MASY.201100059
Degradation Behavior of Porous Copolyester Microparticles in the Light of Dynamic Changes in Their Morphology
Simi Mathew (2011)
10.1007/s13233-013-1054-1
Preparation and characterization of valsartan-loaded polyoxalate microspheres: In vitro release profiles
J. K. Lee (2013)
10.1089/TEN.TEA.2013.0403
Hyaluronidase-loaded PLGA microparticles as a new strategy for the treatment of pulmonary fibrosis.
da Silva BitencourtClaudia (2015)
10.5301/IJAO.2011.6392
Solutions for Lipophilic Drugs: A Biodegradable Polymer Acting as Solvent, Matrix, and Carrier to Solve Drug Delivery Issues
Lutz R Asmus (2011)
10.4236/ACES.2017.74025
Physicochemical Properties and Control Release of Aloe Vera (Aloe barbadensis Miller) Bioactive Loaded Poly (Lactic Co-Glycolide Acid) Synthesized Nanoparticles
L. Kassama (2017)
10.21767/2469-6692.10008
Towards a computational prediction of nanoparticle pharmacokinetics and distribution
M. Siccardi (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar